DUVYZAT
Live / Registered — Registered (as of 04 Mar 2025)
What this means for you
Registered since 04 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97342645
- Registration number
- 7715681
- Mark type
- Stylized text
- Filed
- 01 Apr 2022
- Published for opposition
- 07 Mar 2023
- Registered
- 04 Mar 2025
- Attorney of record
- John Pickerill
Goods and services
- Class 005 — Pharmaceuticals: Biochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders
Owner
- ITALFARMACO S.p.A., Milano, IT
- ITALFARMACO S.p.A., Milano, IT
- ITALFARMACO S.p.A., Milano, IT
Prosecution history
- 04 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Oct 2024 — USE AMENDMENT FILED
- 15 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 12 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Apr 2024 — SOU EXTENSION 2 GRANTED
- 11 Apr 2024 — SOU EXTENSION 2 FILED
- 11 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 25 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2023 — SOU EXTENSION 1 GRANTED
- 23 May 2023 — SOU EXTENSION 1 FILED